Quantcast

Latest DNA vaccination Stories

2014-05-05 04:22:00

BLUE BELL, Pa., May 5, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its first quarter 2014 financial results on Monday, May 12, 2014, at 8:30 a.m. ET. Management will discuss first quarter earnings and expectations for the current and upcoming quarters. The audio presentation will be broadcast online at http://www.investorcalendar.com/IC/CEPage.asp?ID=172676. Investors can also access...

2014-04-01 04:20:52

Immunotherapy and Vaccine Leader Also Promotes Three Executives in Legal, Clinical and Investor Relations BLUE BELL, Pa., April 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support...

2014-03-30 23:04:37

VGXI announced today that the corporation won the award for Best CMO at the 7th Annual ViE Awards Ceremony held at the 2014 World Vaccine Congress in Washington, D.C. The Woodland's, TX (PRWEB) March 30, 2014 For the second year in a row, VGXI, Inc. was awarded the title of Best Contract Manufacturing Organization (CMO) at the Annual ViE Awards Ceremony held at the World Vaccine Congress in Washington, D.C. on March 25, 2014. VGXI is a leading provider of DNA plasmid manufacturing...

2014-03-26 04:20:59

Biotech Judged First-in-Class for Cervical Pre-Cancer Immunotherapy (VGX-3100), Which Reports Phase II Results Mid-year 2014 BLUE BELL, Pa., March 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic...

2014-03-17 04:21:39

BLUE BELL, Pa., March 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended December 31, 2013, as compared to $1.1 million and $4.1 million for the same periods in 2012. Total operating expenses for the quarter and year and ended December 31, 2013, were $9.7 million and $33.0 million as compared to...

2014-03-14 23:22:14

The factors responsible for the growth of the animal vaccine market include increasing incidences of zoonotic diseases in humans, growing prevalence of animal diseases, and increasing investments by government bodies, animal welfare associations, and leading players. http://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html (PRWEB) March 14, 2014 The “"Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion -...

2014-03-12 04:21:10

BLUE BELL, Pa., March 12, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its fourth quarter and year end 2013 financial results on Monday, March 17, 2014 at 8:30 a.m. ET. Management will provide an update on the company, discuss fourth quarter and year end results, and discuss expectations for 2014. The audio presentation will be broadcast online at...

2014-02-26 16:28:53

BLUE BELL, Pa., Feb. 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as joint bookrunning managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be...

2014-02-19 16:21:15

DUBLIN, Feb. 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/frs7k2/animalveterinary ) has announced the addition of the "Concise Analysis of the International Animal/Veterinary Vaccines Market - Global Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The animal vaccines market studied is segmented by products, animal diseases, and technologies that are involved in developing vaccines for...

2014-02-19 04:22:25

BLUE BELL, Pa., Feb. 19, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the company at the Cowen and Company 34th Annual Health Care Conference in Boston, MA. Cowen and Company 34th Annual Health Care Conference March 3-5, 2014Boston Marriott Copley PlaceBoston, MA Inovio PresentationMonday, March 3(rd)2:50 PM ET A live and archived webcast of Dr. Kim's presentation...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related